Patents by Inventor Clara Nahmias

Clara Nahmias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ATIP3 AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20130345145
    Abstract: The present invention concerns a combination of (i) a polypeptide comprising ATIP3 or a biologically active fragment thereof, and (ii) a chemotherapeutic drug that is an antimitotic agent, for simultaneous or sequential use in the treatment of a patient suffering from cancer, e.g. a triple-negative breast cancer. The present invention also relates to a polypeptide comprising ATIP3 or a biologically active fragment thereof, for use in sustaining drug effect, increasing or restoring or enhancing sensitivity of a patient suffering from cancer to a chemotherapeutic drug that is an anti-mitotic agent. The present invention further provides biologically active polypeptides that comprise or consist of fragments of ATIP3, and antibodies binding thereto.
    Type: Application
    Filed: March 12, 2012
    Publication date: December 26, 2013
    Applicants: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS DESCARTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S)
    Inventors: Clara Nahmias, Sylvie Rodrigues-Ferreira
  • Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications
    Publication number: 20060040277
    Abstract: The invention concerns nucleic sequences coding for a protein capable of interacting with the AT2 receptor, oligonucleotides included in said sequences, their application as probes and for expressing said proteins, vectors useful for said expression, host cells containing said vectors, and study model of AT2 receptor. The invention also concerns said proteins and their uses. Said isolated nucleic acid fragment coding for a protein capable of binding with the AT2 receptor is selected among the group consisting of the sequences SEQ ID NO: 1, 3, 5, 7 and 9.
    Type: Application
    Filed: October 29, 2004
    Publication date: February 23, 2006
    Inventors: Nathalie Elbaz, Clara Nahmias, Donny Strosberg Arthur
  • Nucleic sequences coding for an AT2 interacting proteins interacting with the AT2 receptor and their applications
    Patent number: 6835539
    Abstract: The invention concerns nucleic sequences coding for a protein capable of interacting with the AT2 receptor, oligonucleotides included in said sequences, their applications as probes and for expressing said proteins, vectors useful for said expression, host cells containing said vectors, and study model of AT2 receptor. The invention also concerns said proteins and their uses. Said isolated nucleic acid fragment coding for a protein capable of binding with the AT2 receptor is selected among the group consisting of the sequences SEQ ID NO: 1, 3, 5, 7 and 9.
    Type: Grant
    Filed: October 8, 2001
    Date of Patent: December 28, 2004
    Inventors: Nathalie Elbaz, Clara Nahmias, Arthur Donny Strosberg
  • Nucleotide sequences encoding the murine .beta.3-adrenergic receptor and their applications
    Patent number: 5691155
    Abstract: Nucleotide sequences encoding the murine .beta.3-adrenergic receptor are provided. Use of the sequences as probes, in vectors, and for the expression of peptides are discussed. Methods of screening substances for agonist or antagonist action towards .beta.3-adrenergic receptors, and for detecting the affinity of various substances for .beta.3-adrenergic receptors, are described.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: November 25, 1997
    Assignee: Centre National De La Recherche Scientifigue
    Inventors: Clara Nahmias, Laurent Jean Emorine, Arthur Donny Strosberg